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1. Introduction 
The term stress was introduced into the biomedical field by Hans Selye (1936) in reference to 
a General Adaptation Syndrome which would consist of all non-specific systemic reactions 
that occur during an intense and chronic exposure to a stressor (e.g., pressure at work and 
poor diet). This syndrome would be different from the specific adaptive reactions (such as 
muscle hypertrophy caused by exercise performed on a regular basis) and immune 
responses (Selye, 1936). 
A study evaluating occupational stress in nurses presented the most common symptoms 
involved: a feeling of fatigue, headache or muscle pain due to tension (neck and shoulders), 
decreased sexual interest, a feeling of discouragement in the morning, sleep difficulties, 
upset stomach or stomach pain, muscle tremors, feeling short of breath or shortness of 
breath, decreased appetite, tachycardia when under pressure, sweating and flushing 
(Stacciarini & Tróccoli, 2004). The main psychological symptoms present in people with 
stress are anxiety, tension, insomnia, alienation, interpersonal difficulties, self-doubt, 
excessive worry, inability to concentrate, difficulty relaxing, anger and emotional 
hypersensitivity (Lipp, 1994). 
Stress has been considered one of the biggest causes of depression. After a situation of great 
stress, approximately 60% of individuals develop depression. Psychosocial problems (work 
pressure, job loss and debt) can also be preconditions for its emergence (Kendler et al. 1995; 
Post, 1992). 
Major depression is a mood disorder whose prevalence throughout life, depending on the 
population, is estimated at between 0.9 to 18% and involves a significant risk of death 
(Waraich et al., 2004). It is estimated that men and women with depression are 20.9 and 27 
times, respectively, more likely to commit suicide than those without depression (Briley & 
Lépine, 2011). 
Multiple environmental factors have been associated with the etiology of depression. 
Adverse events during childhood and everyday stress are described as important factors for 
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the development of depression (Kessler, 1997). Children with a history of sexual abuse, living 
in troubled homes or who receive little attention from parents have a high risk of becoming 
depressed adults (Kessler, 1997). Stressful events such as the loss of a loved one, job loss, or 
partner separation are factors associated with the onset of depression (Kessler, 1997). 
Individual personality is also a predisposing factor to depression, as evidenced by the higher 
frequency of depression in people with a tendency to be sad when they experience a stressful 
event (Fava & Kendler, 2000). Gender is strongly associated with depression. Studies have 
shown that depression is on average twice as common in women as in men (Bromet et al., 
2011). Interestingly, a decrease in the female/male proportion of depression has been observed 
in young adults (18 to 24 years), possibly due to greater gender equality in today’s society 
(Seedat et al., 2009). Besides environmental factors, individual genetic characteristics also 
contribute to susceptibility to depression (Jabber et al., 2008). 
In addition to the psychological changes associated with depression, immune system 
changes are often found in depressed individuals (Altenburg et al., 2002). Several studies 
have indicated that stress and depression involve the individual in a chronic process that 
results in host defense failure against microorganisms and a higher likelihood of developing 
certain cancers. These alterations are probably associated with profound changes in the 
functioning of the immune system of individuals suffering from depression (Reiche et al., 
2004; Irwin et al., 2011). Epidemiological and experimental evidence shows that changes in 
the defense capability of the individual are related to decreased proliferative capacity of 
peripheral blood lymphocytes stimulated with mitogens in vitro (Schleifer et al., 1985; 
Schleifer et al., 1996), a decrease in the cytotoxic activity of natural killer cells (NK) (Schleifer 
et al., 1996; Calabrese et al., 1987; Nunes et al., 2002), the suppression of T-cell activity due to 
increased apoptosis and decreased cell proliferation in response to antigens (Szuster-
Ciesielski et al., 2008; Schleifer et al., 1984). Moreover, imbalance in cytokine levels is often 
observed, such as increased levels of interleukin 2 (IL-2), interleukin 6 (IL-6) and interferon-
alpha (IFN-α) (Seidel et al. 1995; Vismari et al., 2008). The results have been conflicting 
regarding humoral immune response and immunoglobulin levels in the blood. A significant 
increase in IgM levels in patients with depression was observed by Kronfol (1989) and Song 
et al. (1994), although other studies have been unable to detect significant changes in 
immunoglobulin levels in the peripheral blood of patients with depression (Bauer et al., 
1995; Nunes et al., 2002). These changes in the immune system probably directly and/or 
indirectly compromise host immunity against microorganisms (Miller, 2010). On the other 
hand, the immune system changes observed in individuals with depression may not be 
caused by changes in the central nervous system of these individuals but instead may be 
directly related to the origin of such changes, including the development of a pro-
inflammation state directly related to the onset of a depressive state, which is suggested by 
the hypothesis that macrophages act as a cause of depression (Miller, 2010). This hypothesis 
is related to an increased secretion of proinflammatory cytokines such as interleukin 1 (IL-1), 
IFN-α, and the resulting change in production of corticotrophin-releasing factor (CRF) and 
adenocorticotrophic hormone (ACTH) (Smith, 1991). 
Importantly, animal models of stress and depression have shown immune system changes, 
including increased production of IL-1, the number of circulating neutrophils and lowered 
resistance to infection by bacteria. Mice that had been transgenically modified to exhibit a 
depressive type of behavior (catalepsy) and were inoculated with sheep red blood cells 
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(SRBC) had lower amounts of platelet-forming cells and antigen-specific T lymphocytes 
than their parents without this disorder. In rats with high levels of anxiety, lower 
concentrations of specific T lymphocytes were also found five days after inoculation with 
SRBC (Kubera et al., 1996; Pedersen & Hoffman-Goetz, 2000; Altenburg et al., 2002; Robles et 
al., 2005; Alperin et al., 2007; Loskutov et al., 2007; Miller, 2010). 
Because this disorder severely compromises the functioning of individuals, several 
alternative treatments for depression have been proposed, including psychotherapy and 
pharmacotherapy, as well as a combination of both types. The use of antidepressant drugs 
for treating patients with depression began in the late 1950s. Since then, many drugs with 
potential antidepressants have been made available and significant advances have been 
made in understanding their possible mechanisms of action (Stahl, 1997). Only two classes 
of antidepressants were known until the 80's: tricyclic antidepressants and monoamine 
oxidase inhibitors. Both, although effective, were nonspecific and caused numerous side 
effects (Lichtman et al., 2009). Over the past 20 years, new classes of antidepressants have 
been discovered: selective serotonin reuptake inhibitors, selective serotonin/norepinephrine 
reuptake inhibitors, serotonin reuptake inhibitors and alpha-2 antagonists, serotonin 
reuptake stimulants, selective norepinephrine reuptake inhibitors, selective dopamine 
reuptake inhibitors and alpha-2 adrenoceptor antagonists (Bezchlibnyk-Butler & Jeffries, 
1999). Serotonin reuptake inhibitors belong to this new generation of antidepressant drugs; 
fluoxetine is the most commonly prescribed drug for treating depression and anxiety 
because of its efficacy, safety and tolerability (Egeland et al., 2010). 
Despite the current extensive use of antidepressant drugs, few studies have investigated the 
effects of antidepressant drugs on the immune system (Janssen et al., 2010). Experimental 
and clinical evidence suggests that changes in the immune system in patients with 
depression can be reversed by the use of antidepressant drugs (Leonard, 2001). 
In animal models the use of fluoxetine has been associated with significant changes in 
immunity. Laudenslager & Clarke (2000) inoculated rhesus monkeys (Macaca mulatta) with 
tetanus toxoid and found increased levels of IgG anti-tetanus. When analyzing the effect of 
the antidepressant desipramine and fluoxetine, it was observed that animals treated with 
these antibodies showed higher plasma levels than those treated with saline. 
Some studies with mice have showed the effects of fluoxetine on humoral immune response. 
Kubera et al. (2000) observed that continuous administration of fluoxetine in C57BL/6 mice 
for four weeks results in decreased IL-4 production and in increased IL-6 and IL-10 
production. Genaro et al. (2000) found that fluoxetine has an inhibitory action on the 
proliferation of B lymphocytes induced by lipopolysaccharide (LPS) or anti-IgM. On the 
other hand, fluoxetine increases the proliferative action of B lymphocytes, being stimulated 
by suboptimal concentrations of anti-IgM. In an experimental model of depression in 
BALB/c, Edgar et al. (2002) observed a decrease in lymphoproliferative response induced by 
mitogens (phytohemagglutinin and concavalina A), an increase in the proliferative response 
of B lymphocytes to lipopolysaccharide (LPS) and that the chronic administration of 
fluoxetine reverses these immune changes. 
The experimental investigation of depression in humans is largely ethically unfeasible. 
Thus, animal models of depression have been developed for this purpose, such as the 
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olfactory bulbectomy, learned helplessness, restraint stress and forced swimming (Willner, 
1990). Forced swimming is a widely used model for preclinical evaluation of the possible 
effects of antidepressant drugs (Porsolt et al., 1977). Its widespread use is mainly due to its 
ease of implementation, the reliability of its results confirmed in various laboratories and its 
ability to detect the action of almost all classes of currently available antidepressants (Borsini 
& Meli, 1988). 
In this study we evaluated the humoral immune response of rats chronically submitted to a 
model of stress/depression, i.e., forced swimming for twenty-five days and daily treatment 
with fluoxetine. Antibody production was assessed five days after the rats were inoculated 
with sheep red blood cells and, after the last day of forced swimming, the animals were 
euthanized and the adrenal glands, thymus and spleen were removed and weighed. 
A growing number of people are diagnosed with stress and depression, for which 
antidepressant drugs are increasingly prescribed. Although many of their effects on 
individuals are known, there have been few studies reporting the effects of antidepressants 
on human and/or animal immune systems, especially regarding humoral immunity. 
Although experimental, this study has great social significance principally due to the large 
number of people vaccinated annually who are also undergoing regular treatment with 
antidepressants. The objective of this study was to evaluate the humoral immune response 
of Wistar rats submitted to forced swimming and treated with fluoxetine. 
2. Methodology  
2.1 Animals and experimental groups 
A sample of 72 male Wistar rats with a body mass of about 300 grams was obtained from 
the Central Vivarium of the State University of Londrina’s Center of Biological Sciences for 
use in the experiment. 
The experiment was conducted at the vivarium of the Department of General Psychology 
and the Behavior Analysis Center of Biological Sciences of the State University of Londrina. 
The rats were housed in polypropylene cages (40 cm x 34 cm x 17 cm) with up to six animals 
per cage. Water and feed were provided ad libitum throughout the experiment, the 
vivarium temperature was maintained at approximately 25°C and a 12 hour light/dark 
cycle was established (light from 7:00 am). The animals’ body weight was measured daily 
before the forced swimming session. 
In order to study the effects of chronic forced swimming, chronic fluoxetine treatment and 
an immunization protocol, roughly half of the animals were submitted to chronic forced 
swimming sessions and the rest were kept in the vivarium. Each of these groups was 
subdivided and treated chronically with fluoxetine or saline. Again, each of the four groups 
was subdivided with part of the animals submitted to the immunization protocol and the 
other part not. Thus, the following eight groups were involved in the procedure: control 
saline not immunized (Ctl-Sal-n-Im, n=10); control saline immunized (Ctl-Sal-Im, n=10); 
control fluoxetine not immunized (Ctl-Fxt-n-Im, n=9); control fluoxetine immunized (Ctl-
Fxt-Im, n=9); swimming saline not immunized (Swm-Sal-n-Im, n=10); swimming saline 
immunized (Swm-Sal-Im, n=10); swimming fluoxetine not immunized (Swm-Fxt-n-Im, 
n=7); swimming fluoxetine immunized (Swm-Fxt-Im, n=7). 
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The experimental procedures were approved by the Ethics Committee on Animal 
Experimentation of the State University of Londrina, Project No. 6977, Case No. 
16828/2010. 
2.2 Protocol of forced swimming 
The forced swimming model was performed in accordance with Lucki (1997) to evaluate the 
acute effect. In the current study, forced swimming sessions were performed daily for 
twenty-five days and the behavior of the animals was rated on the first and last day. Forced 
swimming was performed in a black plastic cylinder (50 cm high and 22 cm in diameter) in 
which the water was 30 cm deep and kept at 25 ± 2°C. The sessionss were performed 
individually for 15 minutes between 12 and 2 pm. At the end of the session, each animal was 
removed from the cylinder and dried. The cylinder was cleaned and the water replaced 
between use by different groups.  
2.3 Fluoxetine: Dilution and application 
We used the drug Daforin® (fluoxetine hydrochloride 20mg/ml) diluted 1:2 in saline 
solution for the experiment. Thirty minutes after the end of each forced swimming session, 
the animals received 10 mg/kg/day of fluoxetine or saline intraperitoneally (i.p.). The 
injections began at the first session (pretest) and finished on the penultimate day of the 
experiment (the 24th day). 
2.4 Behavioral evaluation 
For behavioral analysis, the animals were filmed during the first five minutes of the 1st and 
the 25th session of forced swimming. After the tests, the videos were stored on a computer 
for further analysis. 
The amount of time the animals spent in the following behaviors was recorded: floating 
(complete immobility or faint movements, i.e., the minimum necessary to keep the 
nose/head above the surface), climbing (vigorous movements with forepaws above the 
surface or against the cylinder wall) and swimming (horizontal movement without the front 
legs breaking the surface of the water). The behavioral data were recorded by a trained 
observer (minimal intra-observer agreement: 0.85). 
2.5 Blood collection and immunization 
On days 5, 10 and 25 of the study at the end of the forced swimming session, all animals 
were sedated by non-lethal inhalation of ethyl ether and approximately 1 mL of blood was 
collected by cardiac puncture. The collected blood was stored in 1.5 ml plastic tubes 
containing 50 μL of 5% EDTA. On days 5 and 20 the animals belonging to subgroups Ctl-
Sal-Im, Ctl-Fxt-Im, Swm-Sal-Im and Swm-Fxt-Im, were inoculated i.p. with a 250 μl solution 
of 2.5% SRBC. 
2.6 Preparation of antigen 
The following protocol was used to extract proteins from sheep erythrocytes: the sheep red 
blood cells were centrifuged in test tubes at a speed of 1000g for 15 minutes. The cell pellet 
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was then suspended in saline, centrifuged at 1000g for 15 minutes and the leukocyte layer 
was removed (this process was repeated twice more). After the third wash, the supernatant 
was removed and 30 ml of Tris-EDTA [5 mM buffer 2-Amino-2-hydroxymethyl-propane-
1,3-diol/hydrochloric acid (Tris-HCl), pH 7.6, containing 1 mM Ethylenediamine tetraacetic 
acid (EDTA)] was added. The tubes were subjected to centrifugation at 25000g for 30 
minutes (this process was repeated until the supernatant had turned pink). The contents of 
the tubes were then filtered through cheesecloth and underwent a final wash with Tris-
EDTA. The pellet obtained was suspended in 0.1% Sodium Dodecyl Sulfate (SDS) in 
Phosphate Buffered Saline (PBS) at a volume three times that of the pellet. The suspension 
was dialyzed for 24 hours at room temperature and the PBS/SDS solution was changed at 
least twice. Aliquots of the suspension were stored at -20°C. The protein suspension dosage 
followed Bradford (1976). 
2.7 Sacrifice 
On the 25th day of study, after finishing the forced swimming test, the animals were again 
non-lethally sedated by inhalation of ethyl ether for blood collection, after which the animals 
were sacrificed by lethal ethyl ether inhalation. The spleen, thymus and adrenal glands of 
each rat were subsequently removed to assess the relative weight. 
2.8 ELISA 
To assess the production of antibodies (IgM, IgG1 and IgG2a), an enzyme-linked 
immunosorbent assay (ELISA) containing 100 µl of a solution of 2.5 mg/ml sheep 
erythrocyte proteins obtained in the above-described manner was added to each well. The 
plasma was diluted 1:100. The dilutions of peroxidase conjugated anti-IgM, anti-IgG1 
(Zymed) and anti-IgG2a (BETHYL) were 1:10000, 1:20000 and 1:5000, respectively.  
ELISA was conducted according to the following protocol: first, the 96-well plates were 
coated with 100 µl of the antigen diluted in carbonate-bicarbonate pH 9.6 and incubated 
overnight at 4°C. The plates were then washed 3 times with PBS-Tween 0.05% and blocked 
with 150 µl of PBS with skim milk (PBS-milk) 5% in each well for 1 h at 25°C. After 3 washes 
with PBS-Tween 0.05%, plasma samples diluted in PBS-milk 1%  (100 µl of 1:100 diluted 
sample per well) were incubated for 1 h at 25°C. The plates were then washed 3 times with 
PBS-Tween 0.05% and the conjugate (100 µl of conjugate diluted in PBS-milk 1% per well) 
anti-IgM, anti-IgG1, or anti-IgG2a was incubated for 1 h at 25ºC, washed 3 times with PBS-
Tween 0.05%, and then the substrate (sodium acetate buffer 0.1 M pH 5, containing TMBZ – 
tetramethylbenzidine of 1% and H2O2 - hydrogen peroxide 0.005%) was added (100 µl of 
substrate/well). After incubation in the dark for 15 minutes at 25°C, 50 µl of 1N H2SO4 was 
added per well. Reading was performed in a microplate reader at 450 nm. 
2.9 Statistical analysis 
Statistical analysis was performed with Statistica 5.0®. To evaluate homogeneity and 
normality, the Levene and Kolmogorov-Smirnov tests were used. To evaluate antibody 
production (IgM, IgG1 IgG2a),  four-way repeated-measures ANOVA was performed 
including the effects of the swimming sessions (Ctl X Swm), fluoxetine treatment (sal X fxt), 
immunization (n-Im X Im) and repeated measurement factor of blood sampling time 
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(preImmunization X after the 1st immunization X after the 2nd immunization). Behavioral 
comparisons were also performed by means of four-way ANOVAs, but with a different 
repeated-measures factor (Session 1 x Session 25). Repeated-measures comparisons of the 
following masses were conducted: body (fluctuation), spleen, adrenal gland and thymus. 
Therefore, the above described remaining factors were analyzed in three-way ANOVAs run 
for this purpose. When interactions of main effects were found to be significant, Tukey post 
hoc tests were applied. The significance level was set at P <0.05. 
3. Results 
Figure 1a shows the production values of IgM antibody groups. The results show no effects 
for stress (F [1.64] = 0.348, P> 0.05), but effects for immunization (F [1.64] = 20.050, P <0.001), 
drug (F [1.64] = 6.673, P <0.05), time (F [2.128] = 32.208, P <0.001), interaction between 
immunization and time (F [2.128] = 21.710, P <0.001), drug and time (F [2.128] = 7.383, P 
<0.001) and immunization, drug and time (F [2.128] = 9.268, P <0.001). Comparing the pre, 
post1 and post2 immunization periods, the Tukey test showed that there was an increase in 
IgM production only for the Ctl-Sal-Im and Swm-Sal-Im groups. We observed that only 
animals treated with saline responded to inoculation with SRBC, while fluoxetine inhibited 
the production of antibodies. 
The production of IgG2a antibody (Figure 1b) appeared to be similar to the values observed 
for IgM. Four-way ANOVA showed no stress effect (F [1.64] = 1.188, P> 0.05), but effects for 
immunization (F [1.64] = 26.326, P <0.001), drug (F [1.64] = 7.139, P <0.05), time (F [2.128] = 
25.483, P <0.001) , immunization and drug interaction (F [1.64] = 7.814, P <0.01), 
immunization and time (F [2.128] = 25.734, P <0.001), drug and time (F [2.128] = 6.578, P < 
0001) and immunization, drug and time (F [2.128] = 6.630, P <0.01). In the pre, post1 and 
post2 immunization periods, the Tukey test showed increased production of IgG2a only in 
Ctl-Sal-Im and Swm-Sal-Im. Only non-stressed animals treated with saline responded to 
inoculation with sheep red blood cells, while fluoxetine inhibited the production of 
antibodies. 
Figure 1c shows the production values for IgG1 antibody. There were no effects for stress (F 
[1.64] = 0.404, P> 0.05) drug (F [1.64] = 0.001, P> 0.05), but effects for immunization (F [1.64] 
= 48.908, P <0.001), time (F [2.128] = 81.116, P <0.001), interaction between stress and drug (F 
[1.64] = 9.370, P <0.01), immunization and time (F [2.128] = 67.428, P <0.001), stress, 
immunization and drug (F [1.64] = 11.223, P <0.01), stress, drug and time (F [2.128] = 
18.953, P <0.001) and stress, immunization, drug and time (F [2.128] = 20.187, P <0.001). 
Comparing the pre, post1 and post2 immunization periods, an increase in IgG1 
production was observed only for the Ctl-Sal-Im and Swm-Fxt-Im groups. It was observed 
that stress and fluoxetine in isolation inhibit the production of IgG1, but that stress and 
drugs together interacted to cause antibody production similar to that of the control 
group (Ctl-Sal-Im). 
The variation in rat body mass was not altered by immunization (F [1.64] = 0.34, P> 0.05), 
although stress (F [1.64] = 19.948, P <0.001) and drug effects (F [1.64] = 111.595, P <0.001) 
were observed. There was no significant interaction between variables. Intergroup 
comparison revealed that fluoxetine was responsible for reducing body mass (Figure 2). 
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Fig. 1. Variation (mean ± SEM) in the production of antibody. We analyzed the variation in 
the production of antibodies (IgM, IgG2a and IgG1) at three different points in time (pre-
immunization, five days after the first immunization and 5 days after the second 
immunization). Fluoxetine was responsible for suppressing the production of IgM (a) and 
IgG2a (b). In relation to IgG1 (c), the administration of only stress and fluoxetine impaired 
antibody production. However, the interaction between these variables did not impair 
production. * Different the pre-immunization and 5 days after the first immunization (P 
<0.001); #Different from Ctl-Sal-Im 5 days after the second immunization (P <0.001); º 
Different Swm-Sal-Im 5 days after the second immunization (P <0.002). 
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Fig. 2. Variation (mean ± SEM) in body mass. It was observed that both fluoxetine and 
swimming resulted in reduced body mass. @ Different the saline group that underwent the 
same treatment (P < 0.05); § Different from the control group that underwent the same 
treatment (P < 0.05). 
There was no stress (F [1.64] = 2.660, P> 0.05) or immunization effect (F [1.64] = 0.373, P> 
0.05) on the relative mass of the adrenal glands. There was a significant effect for drug (F 
[1.64] = 38.558, P <0.001) and interaction between drugs and immunization (F [1.64] = 2.479, 
P <0.05). The Tukey test showed an increase in relative mass of the adrenal group Swm Fxt-
n-Im compared to its control Swm-Salt-n-Im (Table 1). 
There was no stress effect on the relative mass of the spleen (F [1.64] = 0.728, P> 0.05), but 
there was a drug effect (F [1.64] = 19.534, P <0.001, Table 1). Nevertheless, there was no 
significant difference between groups in post hoc comparisons. 
There was no stress (F [1.64] = 0.276, P> 0.05) or immunization effect (F [1.64] = 0.704, P> 
0.05) on relative thymus mass, but a drug effect (F [1.64] = 32.504, P <0.001) and an 
interaction between stress and drug (F [1.64] = 7.535, P <0.05) was detected. It was observed 
that the drug reduced the relative mass of the thymus in unstressed animals treated with 
fluoxetine (Table 1). 
 Control Swim 
Organ Saline Fluoxetine Saline Fluoxetine 
 n-Im Im n-Im Im n-Im Im n-Im  Im 
Adrenals 6.6 ± 0.6 7.6 ± 0.3 9.7 ± 0.7 10.0 ± 0.8 6.9 ± 0.8 7.7 ± 0.8 13.1 ± 1.6  9.8 ± 0.5 
Spleen 158.4 ± 3.4 150.4 ± 5.6 222.2 ± 27.7 206.8 ± 26.8 143.4 ± 5.2 164.0 ± 7.6 202.0 ± 20.5  189.5 ± 18.0 
Thymus 66.2 ± 4.3 71.5 ± 3.8 36.0 ± 7.3 36.1 ± 5.0 54.9 ± 5.1 57.4 ± 5.7 42.1 ± 7.9  47.2 ± 3.4 
Table 1. Relative mass of the adrenal glands, spleen and thymus of rats at the end of the 
experiment. It was observed that fluoxetine was responsible for changing the relative mass 
of the three organs analyzed, with the adrenal glands and thymus increased and the spleen 
reduced (P <0.05). Measure (1 = 0.001% of the body mass).  
Figure 3a shows the duration of floating behavior. Statistical analysis showed no effects for 
immunization (F [1.30] = 0.078, P> 0.05) or drug (F [1.30] = 1.099, P> 0.05) but effects for time 
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Fig. 3. Variation in the time of analyzed behaviors. Fluoxetine treatment increased floating 
(a) and reduced climbing (c) behavior between Session 1 and 25; no alteration was found in 
swimming behavior (b). The animals treated with saline did not show significant alterations 
in behavior between sessions. *, significant difference compared to Session 1 (P <0.01). @, 
significant difference in the same session compared to the saline group that had been 
otherwise submitted to the same treatment (P <0.05). 
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(F [1. 30] = 30.010, P <0.001). An interaction between factors occurred only with drug and 
time (F [1.30] = 5.989, P <0.05). Comparing the 1st and the 25th session, a reduction was 
observed only in the nonimmunized, drug treated group. There was also a distinction 
observed between the Fxt-n-Im and Sal-n-Im groups at the 25th session. 
For swimming, statistical analysis revealed no effects for immunization (F [1.30] = 0.208, P> 
0.05), drug (F [1.30] = 0.861, P> 0.05), time (F [1.30] = 0.563, P> 0.05) or interaction of factors 
(Figure 3b). 
Figure 3c shows the time of analyzed behaviors. There were no effects for immunization (F 
[1.30] = 0.081, P> 0.05) or drug (F [1.30] = 0.091, P> 0.05) and effects for time (F [1. 30] = 
32.243, P <0.001). There was an interaction between drug and time (F [1.30] = 5.338, P <0.05). 
Comparing the 1st and 25th sessions, an increase in climbing time was detected in the Fxt-
Im group. 
4. Discussion 
The current study investigated the effects of chronic stress and the administration of the 
drug fluoxetine on humoral immune response. It assessed primary and secondary immune 
response against sheep red blood cells, variation in body mass and the relative mass of the 
adrenal glands, thymus and spleen, as well as the behavior of rats subjected to a daily forced 
swimming protocol, which is an model used to assess depression-like behavior in rodents. 
In general, stress is considered to be an immunosuppressant. Elenkov & Chrousos (1999) 
conducted an extensive review on the influence of stress on the immune system and found 
that acute stress produced subacute or chronic immunosuppressive activity on cellular 
immune response. On the other hand, stress also was found to have an immunostimulating 
effect on humoral immune response. Another literature review Segerstrom & Miller (2004) that 
included research from the last 30 years on the effects of stress on immune function in men 
and women found no relationship between acute and subacute stress regarding modulation of 
humoral immune response. Nevertheless, it was observed that stress is associated with chronic 
immunosuppression in that it lowered antibody capacity against an influenza virus. 
The ability of stress to inhibit cellular immune response (Th1) is probably related 
glucocorticoid and catecholamine suppression of pro-inflammatory cytokines, IL-12, IFN-γ 
and TNF-α (Elenkov & Chrousos, 1999). Regarding the suppression of cellular immune 
response, several studies have shown that stress can cause a predisposition to autoimmune 
diseases (rheumatoid arthritis and type 1 diabetes), allergies (asthma, food allergies and 
emphysema), and some types of cancer, including Kaposi's sarcoma and Epstein-Barr virus 
associated B-cell lymphomas (Reiche et al., 2004). 
On the other hand, the modulation of humoral immune response by stress is a controversial 
topic in the literature because studies differ regarding the possible modulation. Baldwin et 
al. (1995) submitted rats to a stress regime that can be considered subchronic (forced 
swimming for 3-5 days, 60 minutes each session) and found no differences in the production 
of anti-sheep red blood cells between stressed and unstressed rats. Besides studies that have 
found no increase, others have observed a decrease. Kennedy et al. (2005) submitted rats to 
acute restraint stress and found that it did not alter the production of IgG1 (Th2) but 
suppressed the production of IgM and IgG2a (Th1) antibodies. Stanojevic et al. (2003) 
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verified the effects of shock stress for five days in rats and, after immunization with bovine 
serum albumin (BSA), found that there was suppressed production of IgG anti-BSA 
compared to controls upon second exposure to the antigen. Hawley et al. (2006) showed that 
stress caused by high social competition in birds involves a lower production of anti-sheep 
erythrocytes. Rammal et al. (2010) found that anxious mice produced fewer IgA and IgE 
antibodies than their nonanxious counterparts, and when both groups were subjected to 
restraint stress, it appears that all studied antibodies (IgA, IgE and IgG) were suppressed in 
both groups. On the other hand, Guéguinou et al. (2011) analyzed the natural antibodies of 
mice subjected to a rotational velocity model (2 and 3 G-force) for 21 days and found an 
increase in IgG levels of animals subjected to 2Gs. Thus, it can be inferred that the type and 
length of exposure to the stressor has a direct relationship with the modulated production or 
elimination of certain antibodies. 
In our study, the chronic stress of forced swimming did not interfere in the production of 
antibody classes IgM and IgG2a, although the production of IgG1 was suppressed. These 
results are similar to those of Kennedy et al. (2005). The modulation of IgG1 antibody 
production in mice suggests a suppression of the Th2-type response, which in rats is 
associated with the production of antibodies to this class of immunoglobulins. On the other 
hand, the results suggest that the Th1 immune response is not affected by forced swimming 
since we did not observe a change in the levels of IgG2a antibodies. It is important to note 
that the production of antibodies in response to an antigen derived from a complex network 
of cellular interactions that involve the production of molecules with opposite effects, such 
as cytokine IFN-γ in mice, which has a stimulating effect on cellular immune response and 
IgG2a antibody production as well as an inhibiting effect on humoral immune response and 
the production of IgG1 antibody, whereas IL-4 has the opposite effect. The fact that the 
forced swimming model results in the removal of IgG1 antibodies from production suggests 
that, by mechanisms not yet understood, stress results in the modulation of signals involved 
in Th2 response without changing the Th1 response. Whereas there is an antagonistic 
relationship between IFN-γ and IL-4, these results suggest that the stress-modulated 
molecular mechanism does not directly involve the main molecules responsible for 
modulation of antibody production. Recent studies have shown that the role of 
neurotransmitters in immune system function may be more important than previously 
considered (Rosas-Ballina et al., 2011). 
Besides the relationship between stress and humoral immune response, we investigated the 
action of fluoxetine on this relationship. Although the 25 days of forced swimming in the 
present study did not affect the normal production of IgM or IgG2a but inhibited IgG1, we 
can speculate that the chronic use of this model may stimulate cellular immune response. 
The administration of fluoxetine inhibited the production of all immunoglobulin classes 
studied, which shows its general immunosuppressive effect, both for Th1 and Th2. 
However, the interaction of forced swimming x fluoxetine normalized the production of 
IgG1. This suggests that stress alone diverts the immune response to Th1-type, while 
fluoxetine alone has an immunosuppressive effect on humoral immune response. On the 
other hand, administration of fluoxetine in animals subjected to forced swimming can 
modulate the immune response to a Th2 pattern. A study about the effects of fluoxetine on 
humoral immune response showed that mice with rheumatoid arthritis that were treated 
with fluoxetine (10 or 25 mg/kg/day) for seven days had no changes in the levels of anti-
collagen antibodies (IgG1 and IgG2a) (Sacre et al., 2010). This result is at odds with the 
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findings of this study since the time/effect analysis of fluoxetine showed immunosuppression 
of all studied classes of antibodies after twenty-four days of treatment. These results suggest 
that the effect of fluoxetine depends on the physiological state of the animal. It is important to 
note that fluoxetine administered concomitantly with stress can have an immunostimulatory 
effect.  Frick et al. (2009) observed that chronic restraint stress in rats causes decreases in CD4 + 
T lymphocytes and no change in CD8 + T lymphocyte but when treated with fluoxetine, initial 
values of CD4 + T cells were restored. According to Freire-Garabal et al. (1997), stressed rats 
treated with fluoxetine had a higher number of circulating lymphocytes than their control 
counterparts (stressed and not treated with fluoxetine). 
The reduction in specific antibody levels observed in our study is probably related to the 
action of fluoxetine on the production of cytokines and B lymphocytes, the cells responsible 
for producing antibodies, as has been observed in other studies. Kubera et al. (2000) 
demonstrated that the administration of fluoxetine for more than four weeks suppresses the 
production of IL-4, the main stimulus for differentiating T helper cells into Th2 cells. The 
decrease in Th2 production may influence isotype synthesis or immunoglobulin levels. 
Regarding the plasma level of antibodies, Laudenslager & Clarke (2000) observed an 
increase in immunoglobulin class IgM and IgG and a decrease in the levels of specific IgG 
antibodies against the tetanus toxoid immunogen in monkeys (Macaca mulatta). Therefore, 
fluoxetine can induce an increased level of total Ig and a decreased level of specific 
antibodies. However, Sluzewska et al. (1995), studying depressed patients treated with 
fluoxetine, showed a decrease in IL-6, the cytokine responsible for the growth of B 
lymphocytes, which differentiate into antibody producers. Moreover, Genaro et al. (2000) 
observed that fluoxetine had an inhibitory effect on the proliferation of B lymphocytes that 
had been stimulated by LPS. 
The immunosuppressive action of fluoxetine cannot be restricted to the production of 
antibodies. Pellegrino & Bayer (2002) observed that the in vitro proliferation of lymphocytes 
from rats that had received fluoxetine via i.p. (5 mg/kg) was lower than their respective 
controls, suggesting that the antidepressant has an immunosuppressive role for 
lymphocytes. Fazzini et al. (2009) found that three weeks of continued fluoxetine use in rats 
triggered an increase in CD8 + T lymphocytes and reduced CD4 + T cells.  
The immunomodulatory action of fluoxetine probably involves the participation of 
cytokines. Patients with major depression have high levels of IL-6, and treatment with 
fluoxetine for 8 weeks leads to normalization of the cytokine levels (Nishida et al., 2002). 
Frick et al. (2008), studying cancerous rats, observed that fluoxetine treatment has a direct 
relationship with increased production of anti-tumor cytokines (IFN-γ and TNF-α), which 
resulted in lower rates of tumor growth and, therefore, longer survival time. On the other 
hand, Roumestan et al. (2007) found that fluoxetine had an anti-inflammatory effect (5, 10, 
15 and 20 mg/kg) when rats were treated thirty minutes prior to inoculation with LPS and 
reported reductions of 60% in TNF-α levels and 50% in mortality compared to controls. 
Sacre et al. (2010) also observed that fluoxetine had an anti-inflammatory effect in rats with 
rheumatoid arthritis that were treated with 25 mg/kg for seven days, as reflected in reduced 
levels of IL-12 and joint damage. On the other hand, some studies have failed to show a 
relationship between fluoxetine and the modulation of cytokine production (Kubera et al., 
2004; Maes et al. 1995; Jazayeri et al., 2010). Grundmann et al. (2010) treated rats orally with 
10 mg/kg/day of fluoxetine for 21 days and observed no changes in the production of 
proinflammatory cytokines (IL-6 and TNF-α). 
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The production of pro- and anti-inflammatory cytokines due to stress plus fluoxetine is 
dependent on the type of stress and route of drug administration. Sprague-Dawley strain 
rats, after 21 days of restraint stress and chronic oral treatment with fluoxetine (10 mg/kg), 
showed lower production of IL-6 than stressed-only animals, although TNF-α levels 
increased, reaching values similar to those of untreated stressed animals (Grundmann et al., 
2010). On the other hand, Kubera et al. (2006) pre-treated rats with imipramine (5 mg/kg) 1, 
5 and 24 hours before forced swimming and found that the splenocytes of treated animals 
produced more IL-10 than controls (stressed and treated with vehicle), with no IFN-γ 
differences observed in any group. Rogoz et al. (2009) treated rats 1, 5 and 24 hours before 
forced swimming with 10 mg/kg of fluoxetine i.p. and observed that the interaction 
between stress and fluoxetine did not alter the splenocyte production of IL-10 or IFN-γ.  
There are reports that the chronic administration of fluoxetine either causes weight loss 
(Wellman et al., 2003) or prevents weight gain (Gutierrez et al., 2002). In the present study, 
the chronic administration of fluoxetine led to a reduction in body mass when compared 
with saline treatment; this reduction was more pronounced when the animals were treated 
with the drug and subjected to forced swimming. First et al. (2011) treated rats for five 
weeks with fluoxetine (5 mg/kg) and observed reduced body mass. However, when they 
were treated with the drug and submitted to chronic stress with multiple stressors, 
fluoxetine prevented weight loss due to this protocol. Zafir & Banu, (2007) also observed 
weight maintenance by chronic administration of fluoxetine in animals subjected to restraint 
stress. It is important to point out that the above-mentioned studies differed in the degree of 
stress generated. In this study 15 min/day of forced swimming did not prevent the animals 
from gaining weight, but First et al. (2011), using various types of stressors for five weeks 
and Banu & Zafir (2007), using four hours of restraint stress, observed reduced body mass. 
Thus, combined multiple stressors or prolonged restraint seem to be more stressful than 
forced swimming. Considered jointly, these studies indicate two seemingly opposite effects 
of fluoxetine: in the presence of severe stressors known to induce mass reduction, the drug 
prevents such losses, while in the presence of mild stressors, the drug leads to weight loss, 
which suggests an anorexic effect. Human studies have confirmed the anorectic effect of 
fluoxetine in that reductions in body mass from the chronic administration of fluoxetine 
were observed in obese individuals (Wise, 1992). 
Stress affects the mass of the adrenal glands and lymphoid organs such as the thymus and 
spleen. Baldwin et al. (1995) investigated the effects of forced swimming (3 to 5 days, sixty 
minutes per session) and found that the number of rats housed together (one or five) 
influenced the relative masses of the adrenal glands, spleen and thymus, the production of 
corticosterone and body mass. They observed that forced swimming, regardless of the type 
of accommodation, reduced the spleen, thymus and body mass of animals, but did not alter 
the production of corticosterone or the relative mass of the adrenal glands. When the 
animals were subjected to social isolation and forced swimming, however, there was 
increased corticosterone production and adrenal mass in addition to the above-mentioned 
effects, showing that these two models administered separately do not lead to stress, but 
together are stressful. Regarding the chronic effect of forced swimming, Zivkovic et al. 
(2005a) found that after submitting rats to 21 days of this protocol, the thymus weight of 
stressed animals was lower than that of non-stressed animals. In another study by the same 
authors (2005b), blood was collected from rats after their final swimming session for 
analysis of circulating corticosterone levels and it was observed that, even after 21 days of 
chronic forced swimming, corticosterone values remained high. 
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In our study, the adrenal gland mass of Wistar rats submitted to swimming (15 min daily for 
25 days) did not change, which was a further similarity with the findings of Baldwin et al. 
(1995), i.e., body mass reduction in animals submitted to swimming. Our study differed 
from the above-mentioned studies in that our stress model did not lead to changes in spleen 
or thymus mass. Moreover, Connor et al. (1998) observed no changes in Sprague-Dawley 
spleen weight after acute forced swimming, which shows that, depending on the strain and 
stress time, body mass values may or may not vary. 
Fluoxetine is also responsible for changing the mass of the adrenal glands, spleen and 
thymus of rodents. Garabal-Freire et al. (1997) submitted mice to a sound stressor (100 dB, 1 
to 3 hours per day, four to twelve days) and observed a decrease in the number of thymic 
and spleen cells; this stressor also contributed to a reduction in relative thymus weight, a 
condition reversed by treatment with fluoxetine (5 mg/kg). Kubera et al. (2006) treated rats 
with three doses of imipramine 1, 5 and 24 hours before forced swimming and found that 
acute treatment with this drug did not alter the relative thymus weight, but did reduce 
spleen weight. In the present study, 24 days of fluoxetine treatment (10 mg/kg) reduced the 
relative thymus weight and body mass of rats and increased spleen and adrenal gland mass. 
Thus, either chronic treatment with fluoxetine stressed the animals or the change in relative 
adrenal mass is merely a reflection of the change in body mass since the adrenal glands did 
not necessarily increase. However, the sudden loss of body mass would have led to this 
apparent increase. 
The currently-used antidepressants have specific compounds that act on different regions of 
the central nervous system, so it is expected that their use in rats or mice would lead to 
improvement in depression symptoms, i.e., reduced time floating (passive behavior) and 
increased time climbing and/or swimming (active behavior) during a forced swimming 
stressor (Piras et al., 2010). However, increases in climbing and/or swimming are dependent 
on the type of drug administered (Cryan & Lucki, 2000). Page et al. (1999) observed a 
reduction in floating time and an increase in swimming time in rats treated with fluoxetine. 
Carr et al. (2010) used fluoxetine in rats (20 mg/kg) three times before forced swimming 
yielded similar results. Cryan & Lucki (2000) compared fluoxetine and reboxetine in a rat 
forced swimming model and found that both drugs led to reduced flotation time, although 
the former increased swimming time and the latter increased climbing time. 
To investigate the effects of chronic treatment with fluoxetine (10 mg/kg), Hansen et al. 
(2011) treated Wistar rats for 48 days with subcutaneous injections, after which the animals 
were subjected to forced swimming. The results showed that the floating, swimming and 
climbing times of treated rats were similar to those observed when fluoxetine was 
administered 24 hours before the test (acute effect). Pedreañez et al. (2011), studying the 
effects of forced swimming as a chronic stressor, carried out fifteen 30-min forced swimming 
sessions and found that the animals’ active behavior dropped by 84 percent between the 
first and last session. 
In our experiment, forced swimming was performed over a chronic period (twenty-five 
days). The results were expected to be similar to those in the literature (with test-retest 
separated by 24 h) or to those of Pedreañez et al. (2011) for rats subjected to chronic 
swimming. We found that, after the chronic treatment period, the time values were different 
from those observed when the test and retest were separated by 24 h. Stressed animals 
treated with saline had no alterations in floating, swimming or climbing times, indicating 
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that forced swimming, when performed on a chronic basis, is not an appropriate model for 
investigating behavioral changes in rats. It should be pointed out that different strains of 
rats exhibited different behavior in the two studies: the active behavior of Sprague-Dawley 
rats was reduced in Pedreañez et al. (2011) whereas, in the present study, Wistar behavior 
was constant throughout the protocol. 
On the other hand, it was observed that animals treated with fluoxetine significantly increased 
floating time after treatment. Since climbing time was also reduced, we can infer that 
adaptation to the drug also leads to behavioral changes, contradicting expected behavior for 
this model of stress/depression. Two possibilities could explain this: first, chronic treatment 
with fluoxetine engenders passive behavior; second, their reduced body weight made them 
denser, which may have facilitated buoyancy and thus reduced effort expenditure. 
5. Conclusion 
We observed in this study that animals treated with fluoxetine and submitted to a 25 day 
forced swimming protocol had a reduced production of IgM and IgG2a and an increased 
production of IgG1. Considering the unique effect of the drug, the adrenal gland and 
relative spleen weight increased, while thymus weight was reduced. Drug-treated rats lost 
body mass compared to saline-treated rats. Regarding the analyzed behaviors, treatment 
with fluoxetine resulted in distinct changes in acute effect, indicating that swimming is not 
be trusted as a model chronic stressor in rats. However, the alterations observed in this 
study may have important implications for the treatment of depression in humans since 
fluoxetine appears to impair the production of antibodies. Thus the indiscriminate use of 
this drug for non-stressed individuals must be questioned. 
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